Immucell (ICCC) Retained Earnings (2010 - 2026)

Immucell (ICCC) has reported Retained Earnings for 17 consecutive years, with -$11.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 6.45% year-over-year to -$11.4 million; the trailing twelve-month figure through Jun 2026 stood at -$11.4 million (up 6.45% YoY), and the FY2025 full-year result was -$15.2 million, down 7.34% from the prior year.
• Retained Earnings rose to -$11.4 million in Q2 2026 per ICCC's latest filing, from -$15.2 million in the prior quarter.
• Across five years, Retained Earnings topped out at $36.2 million in Q2 2023 and bottomed at -$15.2 million in Q4 2025.
• Historically, Retained Earnings has averaged $1.8 million across 5 years, with a median of -$12.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 138.66% in 2024, then climbed 15.83% in 2025.
• Over 5 years, Retained Earnings stood at -$6.2 million in 2022, then plunged by 92.65% to -$12.0 million in 2023, then retreated by 17.96% to -$14.2 million in 2024, then decreased by 7.34% to -$15.2 million in 2025, then gained by 24.84% to -$11.4 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$11.4 million, -$15.2 million, and -$12.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.